ITERUM THERAPEUTICS PLC ITRMF
SHS · Common Stock · CUSIP G6333L101
14
institutional holders
7.1m
shares reported held*
$31.8mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.50.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| Canaan Partners X LLC 5.04% of their portfolio | 1.7m $7.8m | — |
| Sofinnova Investments, Inc. 0.57% of their portfolio | 1.7m $7.8m | — |
| FRAZIER MANAGEMENT LLC 1.16% of their portfolio | 1.5m $6.9m | — |
| New Leaf Venture Partners, L.L.C. 1.42% of their portfolio | 1.5m $6.6m | — |
| Granahan Investment Management, LLC 0.05% of their portfolio | 244.5k $1.1m | — |
| Ensign Peak Advisors, Inc 0.00% of their portfolio | 230.8k $1.0m | — |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.01% of their portfolio | 88.7k $399.0k | — |
| Virtu Financial LLC 0.01% of their portfolio | 22.4k $101.0k | — |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 18.0k $81.0k | — |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 3.0k $14.0k | — |
| UBS Group AG 0.00% of their portfolio | 1.9k $9.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 1.9k $8.0k | — |
| Cypress Capital Management LLC (WY) 0.00% of their portfolio | 1.0k $5.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |